Mechanism exploration of SanShi ShengXin Ointment in the treatment of pressure ulcers based on network pharmacology and molecular docking

Kai Yang,Chenchen Fei,Xiang Gao
DOI: https://doi.org/10.1097/md.0000000000037390
IF: 1.6
2024-03-13
Medicine
Abstract:Pressure ulcers (PU), localized injuries to the skin or underlying tissue, develop as a result of blood flow obstruction and insufficient tissue nutrition due to sustained pressure on local tissues, which eventually leads to ulceration and necrosis of the skin and underlying tissue. [ 1 ] The elderly are prone to suffer from PU because of slowed skin and soft tissue metabolism, reduced sensory function, and prolonged bed rest. [ 2 ] PU can aggravate disease conditions, prolong hospital stays, increase treatment costs, and in severe cases, cause death due to secondary infection, placing an additional burden on society, families, and healthcare providers. [ 3 ] The US National Pressure Ulcer Advisory Panel (NPUAP) classifies PU into 4 stages according to the pathological characteristics of the injury site: patients at stages I and II are generally treated with routine surgical dressing changes combined with conventional rehabilitation care measures; patients at stages III and IV have more serious conditions and require dressing changes combined with negative pressure drainage techniques or even surgery; non-stage and deep tissue injuries are generally treated with surgical implants. [ 4 ] Currently, the commonly used treatment methods in China include traditional Chinese medicine (TCM), vacuum sealing drainage, dressing therapy, and surgical therapy, [ 5 ] among which TCM is accepted by patients and their families because of its less side effects and low costs. [ 6 ]
medicine, general & internal
What problem does this paper attempt to address?